Skip to main content
SpringerLink
Log in

Myeloproliferative neoplasm in a thalassaemic patient: response to treatment with a JAK inhibitor

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Verstovsek S, Mesa RA, Gotlib J, Levy RS, Gupta V, DiPersio JF, Catalano JV, Deininger MW, Miller CB, Silver RT et al (2013) Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I. Haematologica 98(12):1865–1871

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Cervantes F, Vannucchi AM, Kiladjian JJ, Al-Ali HK, Sirulnik A, Stalbovskaya V, McQuitty M, Hunter DS, Levy RS, Passamonti F et al (2013) Three-year efficacy, safety, and survival findings from COMFORT-II, a phase 3 study comparing ruxolitinib with best available therapy for myelofibrosis. Blood 122(25):4047–4053

    Article  CAS  PubMed  Google Scholar 

  3. Vannucchi AM, Kiladjian JJ, Griesshammer M, Masszi T, Durrant S, Passamonti F, Harrison CN, Pane F, Zachee P, Mesa R et al (2015) Ruxolitinib versus standard therapy for the treatment of polycythemia vera. N Engl J Med 372(5):426–435

    Article  CAS  PubMed  Google Scholar 

  4. Zauber NP, Vlad LD (1995) Myeloproliferative disorders in two New Jersey families. N J Med 92(8):530–532

    CAS  PubMed  Google Scholar 

  5. Rochette J, Barnetson R, Kiger L, Kister J, Littlewood TJ, Webster R, Poyart C, Thein SL (1994) Association of a novel high oxygen affinity haemoglobin variant with delta beta thalassaemia. Br J Haematol 86(1):118–124

    Article  CAS  PubMed  Google Scholar 

  6. Craig JE, Barnetson RA, Prior J, Raven JL, Thein SL (1994) Rapid detection of deletions causing delta beta thalassemia and hereditary persistence of fetal hemoglobin by enzymatic amplification. Blood 83(6):1673–1682

    CAS  PubMed  Google Scholar 

  7. Barosi G, Birgegard G, Finazzi G, Griesshammer M, Harrison C, Hasselbalch HC, Kiladjian JJ, Lengfelder E, McMullin MF, Passamonti F et al (2009) Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference. Blood 113(20):4829–4833

    Article  CAS  PubMed  Google Scholar 

  8. Wilkins BS, Radia D, Woodley C, Farhi SE, Keohane C, Harrison CN (2013) Resolution of bone marrow fibrosis in a patient receiving JAK1/JAK2 inhibitor treatment with ruxolitinib. Haematologica 98(12):1872–1876

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Lopes da Silva R, Silva M (2011) Coexistence of beta-thalassemia and polycythemia vera. Blood Cells Mol Dis 46(2):171–172

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was partially supported by FIS grants PI 12/01728 and Red Temática de Investigación Cooperativa en Cáncer (RTICC) del Instituto de Salud Carlos III RD12/0036/0061 and Fundacion CRIS contra el cancer.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Division of Hematology, Hospital Universitario 12 de Octubre, Departamento de Medicina, Universidad Complutense, Avd de Cordoba s/n., 28041, Madrid, Spain

    Joaquín Martinez-Lopez & Rosa Ayala

  2. Division of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain

    Ana Jimenez

  3. Division of Hematology, Hospital de Mostoles, Madrid, Spain

    Jorge Sanchez-Calero & Dolores Monteagudo

  4. Division of Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain

    María Urbanowicz

  5. Division of Pharmacy, Hospital Universitario 12 de Octubre, Madrid, Spain

    Irene Cañamares-Orbis & Susana Cortijo-Cascajares

Authors
  1. Joaquín Martinez-Lopez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ana Jimenez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jorge Sanchez-Calero
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dolores Monteagudo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. María Urbanowicz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Irene Cañamares-Orbis
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Susana Cortijo-Cascajares
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Rosa Ayala
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joaquín Martinez-Lopez.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Martinez-Lopez, J., Jimenez, A., Sanchez-Calero, J. et al. Myeloproliferative neoplasm in a thalassaemic patient: response to treatment with a JAK inhibitor. Ann Hematol 94, 1237–1239 (2015). https://doi.org/10.1007/s00277-015-2352-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-015-2352-9

Keywords

Search

Navigation